The malignant carcinoid syndrome

William, E. D., andSandler, M. The classification of carcinoid tumors.Lancet 1:238, 1963.PubMedGoogle Scholar

Peart, W. S., Porter, K. A., Robertson, J. I. S., Sandler, M., and Baldock, E. Carcinoid syndrome due to pancreatic duct neoplasm secreting 5- hydroxytryptophan and 5-hydroxytryptamine.Lancet 1: 239, 1963.PubMedGoogle Scholar

Williams, E., andAzzopardi, J. G. Tumors of the lung and the carcinoid syndrome.Thorax 15:30, 1960.PubMedGoogle Scholar

Frank, H. D., andLieberthal, M. M. Carcinoid syndrome originating in bronchial adenoma.Arch Intern Med 111:791, 1963.PubMedGoogle Scholar

Gailitis, R. J., andSchreiber, W. Malignant carcinoid syndrome and latest concepts in serotonin metabolism. Use of cortisone, prednisone, and antiserotonin compound 45–50.Amer J Surg 99:84, 1960.PubMedGoogle Scholar

Green, D., Joynt, R. J., andVan Allen, M. W. Neuromyopathy associated with a malignant carcinoid tumor.Arch Intern Med 114:494, 1964.PubMedGoogle Scholar

Oates, J. A., Melmon, K., Sjoerdsma, A., Gillespie, L., andMason, D. T. Release of kinine peptide in the carcinoid syndrome.Lancet 1:514, 1964.Google Scholar

Mengel, C. E. Cutaneous manifestations of the malignant carcinoid syndrome: Severe pruritus and orange blotches.Ann Intern Med. 6:989, 1963.Google Scholar

Demis, D. J., andZimmer, J. G. Histaminuria and mastocytosis.Arch Intern Med 111:309, 1963.Google Scholar

Mutter, R. D., Tannenbau, M., andUltmann, J. E. Systemic mast cell disease.Ann Int Med 59: 887, 1963.PubMedGoogle Scholar

Warner, R. R. Hyperserotoninemia in functional gastrointestinal disease.Ann Intern Med 39:464, 1963.Google Scholar

Davidson, J., Sjoerdsma, A., Loomis, L. N., and Udenfriend, S. Studies with the serotonin precursor, 5-hydroxytryptophan in experimental animals and man.J Clin Invest 36: 1594, 1957.PubMedGoogle Scholar

Page, I. H., andMcCubbin, G. W. Serotonin or tenure, for the pharmacologist.Circulation 16:161, 1956.Google Scholar

Sothren, A. L. Functioning metastatic bronchial carcinoid with elevated levels of serum and cerebrospinal fluid serotonin and pituitary adenoma.J Clin Endocr 20: 298, 1960.PubMedGoogle Scholar

Schenkloth, R., Page, I. H., Del Greco, F., andCorcoran, A. C. Effects of serotonin antagonists in normal subjects and in patients with carcinoid tumors.Circulation 16:523, 1957.PubMedGoogle Scholar

Peart, W. S., Andrews, T. M., andRobertson, J. I. S. Serotonin release induced with intravenous adrenalin or noradrenalin.Lancet 1:577, 1961.PubMedGoogle Scholar

Levine, R. J., Sjoerdsma, A. Pressoramines and the carcinoid flush.Ann Intern Med 5: 818, 1963.Google Scholar

Hollands, W., Michelson, A. S., andWilkins, R. N. Serotonin and antiserotonins. 1. Their circulatory, respiratory and renal effects in man.Circulation 16: 246, 1957.PubMedGoogle Scholar

Haverbeck, B. J., Hogben, C. A. H., Moran, N. C, andTerry, L. L. Effect of serotonin (5-hydroxytryptamine) and related compounds on gastric secretion and intestinal motility in dogs.Gastroenterology 32: 1058, 1957.PubMedGoogle Scholar

Erspamer, V. Serotonin (5-hydrotryptamine).Physiol Rev. 6:425, 1954.Google Scholar

Erspamer, V. Pharmacology of indolealchylamines.Pharmacol Rev 6:425, 1954.PubMedGoogle Scholar

MacDonald, R. A. Study of 356 carcinoids of the gastrointestinal tract.Am J Med 21:867, 1956.PubMedGoogle Scholar

Hendrix, T. R., Atkinson, M., Clifton, J. A., andIngelfinger, F. G. The effect of 5-hydroxytryptamine on intestinal motor function in man.Amer J Med 23:886, 1957.PubMedGoogle Scholar

Vilkins, R. N., andHollander, W. Serotonin and antiserotonin. H. Clinical studies especially in essential hypertension with benzyl analog of serotonin (b.a.s.).Circulation 16:256, 1957.PubMedGoogle Scholar

Heilmeyer, L., Kuehn, H. A., Clottten, R., andLipp, A. Metastasierendes Duenndarm-carcinoid.Deutsch Med Wschr 81:501, 1956.PubMedGoogle Scholar

Fein, S. B., andKnidson, K. P. The malignant carcinoid syndrome; a case report with biochemical studies.Cancer 9:148, 1956.PubMedGoogle Scholar

McElroy, W. D., and Glass, H. B. (Eds.). “The 5-hydroxyindole Pathway of Tryptophane Metabolism.” In A Symposium on Amino Acid Metabolism. Johns Hopkins Press, Baltimore, 1955.Google Scholar

Jenkins, G. S., andButcher, P. G. A. Malignant argentaffinoma with cyanosis and pulmonary stenosis.Lancet 26:331, 1955.Google Scholar

Pharm, J. B., Fahim, I., Sullivan, F. M., andRobinson, J. M. Possible role of 5-hydroxytryptamine in toxemia of pregnancy.Lancet 2:553, 1963.Google Scholar

Eschbach, J. W., Rinaldo, J. A. Jr. Metastatic carcinoid: a familiar occurrence.Ann Intern Med 57:647, 1962.Google Scholar

Urales, L., Murray, M., Wolf, R. Results of pharmacologic treatment in malignant carcinoid syndrome.New Engl J Med 267:435, 1963.Google Scholar

Reed, M. L. et al. Treatment of disseminated carcinoid tumors including hepatic artery catheterization.New Engl J Med 269:1005, 1963.PubMedGoogle Scholar